de Fijter, C W <br/><br/>
Does additional treatment with fish oil mitigate the side effects of recombinant human erythropoietin in dialysis patients?  [electronic resource] 

 -  Haematologica   
 - 332-4 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0390-6078 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Anemia--therapy<br/>Blood Viscosity--drug effects<br/>Cross-Over Studies<br/>Double-Blind Method<br/>Erythrocyte Deformability--drug effects<br/>Erythropoietin--adverse effects<br/>Fatty Acids--blood<br/>Fish Oils--therapeutic use<br/>Humans<br/>Hypertension--chemically induced<br/>Kidney Failure, Chronic--blood<br/>Phospholipids--blood<br/>Platelet Aggregation--drug effects<br/>Prospective Studies<br/>Recombinant Proteins--adverse effects<br/>Renal Dialysis<br/>Thrombosis--chemically induced<br/>Treatment Failure